UY40852A - Derivados y conjugados de antraciclina y usos de los mismos - Google Patents
Derivados y conjugados de antraciclina y usos de los mismosInfo
- Publication number
- UY40852A UY40852A UY0001040852A UY40852A UY40852A UY 40852 A UY40852 A UY 40852A UY 0001040852 A UY0001040852 A UY 0001040852A UY 40852 A UY40852 A UY 40852A UY 40852 A UY40852 A UY 40852A
- Authority
- UY
- Uruguay
- Prior art keywords
- conjugates
- anthracycline derivatives
- anthracycline
- compounds
- refers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
La memoria descriptiva se refiere a compuestos de antraciclina y conjugados de los mismos. La memoria descriptiva se refiere además al uso de los compuestos y conjugados en el tratamiento del cáncer, y a procedimientos para preparar los compuestos y conjugados.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363518651P | 2023-08-10 | 2023-08-10 | |
| US202463631545P | 2024-04-09 | 2024-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY40852A true UY40852A (es) | 2025-02-14 |
Family
ID=92424190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001040852A UY40852A (es) | 2023-08-10 | 2024-08-09 | Derivados y conjugados de antraciclina y usos de los mismos |
Country Status (3)
| Country | Link |
|---|---|
| TW (1) | TW202525277A (es) |
| UY (1) | UY40852A (es) |
| WO (1) | WO2025032254A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026078165A1 (en) * | 2024-10-10 | 2026-04-16 | Astrazeneca Ab | Conjugates comprising cleavable linkers |
| WO2026078163A1 (en) * | 2024-10-10 | 2026-04-16 | Astrazeneca Ab | Conjugates comprising linkers |
| WO2026162763A1 (en) * | 2025-01-31 | 2026-08-06 | Astrazeneca Ab | Conjugates comprising cleavable linkers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009270988A1 (en) * | 2008-07-15 | 2010-01-21 | Genentech, Inc. | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| TWI725931B (zh) * | 2013-06-24 | 2021-05-01 | 美商建南德克公司 | 抗fcrh5抗體 |
| BR112016017402A2 (pt) | 2014-02-21 | 2017-10-17 | Medimmune Ltd | fusões anti-pcsk9~glp-1 e métodos para uso |
-
2024
- 2024-08-09 WO PCT/EP2024/072665 patent/WO2025032254A1/en not_active Ceased
- 2024-08-09 TW TW113129954A patent/TW202525277A/zh unknown
- 2024-08-09 UY UY0001040852A patent/UY40852A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025032254A1 (en) | 2025-02-13 |
| TW202525277A (zh) | 2025-07-01 |